What is Insulet's revenue?

Insulet (PODD) generated $2.9B in revenue over the trailing twelve months, up 31.9% year over year.

Is Insulet profitable?

Insulet reported $302.8M in net income over the trailing twelve months, a 10.4% net margin.

What are Insulet's profit margins?

Gross margin is 71.0% and operating margin is 17.5%, with a 10.4% net margin.

What is Insulet's earnings per share?

Insulet's diluted EPS over the trailing twelve months is $4.29.

Where does Insulet's income statement data come from?

Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Insulet PODD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$761.7M+33.9%	$783.8M+31.2%	$706.3M+29.9%	$649.1M+32.9%	$569M+28.8%
Total cost of revenue	$232.7M+45.5%	$215.2M+29.2%	$196.2M+17.6%	$196.9M+24.9%	$159.9M+18.5%
Gross profit	$529M+29.3%	$568.6M+32.0%	$510.1M+35.3%	$452.2M+36.7%	$409.1M+33.3%
Gross margin	69.4%-2.4pp	72.5%+0.4pp	72.2%+2.9pp	69.7%+1.9pp	71.9%+2.4pp
Research and development	$89.7M+50.5%	$90.9M+50.0%	$77.2M+40.6%	$73.4M+36.2%	$59.6M+18.7%
Selling, general and administrative	$317.2M+21.7%	$331.4M+27.0%	$315.2M+34.6%	$257.7M+15.8%	$260.7M+30.5%
Operating income	$122.1M+37.5%	$146.3M+33.9%	$117.7M+33.6%	$121.1M+122%	$88.8M+56.1%
Operating margin	16%+0.4pp	18.7%+0.4pp	16.7%+0.5pp	18.7%+7.5pp	15.6%+2.7pp
Interest expense	$14.7M+59.8%	$14.9M+73.3%	$15.6M+25.8%	$19.6M+78.2%	$9.2M-14.0%
Other income (expense), net	$700K+132%	$3.1M—	$12.1M+456%	$1.3M+172%	-$2.2M-214%
Income before income taxes	$113M+134%	$140.2M+25.9%	$122.8M+48.1%	$28.4M-44.4%	$48.2M-12.2%
Income tax expense	$21.9M+72.4%	$38.5M—	$35.2M+552%	$5.9M+104%	$12.7M+274%
Net income	$91.1M+157%	$101.6M+0.9%	$87.6M+13.0%	$22.5M-88.1%	$35.4M-31.3%
Net margin	12%+5.7pp	13%-3.9pp	12.4%-1.8pp	3.5%-35.1pp	6.2%-5.4pp
Diluted earnings per share	$1.30+160%	$1.43+3.6%	$1.24+14.8%	$0.32-87.6%	$0.50-31.5%
EBITDA	$148.3M+34.2%	$170.7M+30.5%	$139.7M+27.7%	$143.4M+94.6%	$110.5M+46.0%
EBITDA margin	19.5%0.0pp	21.8%-0.1pp	19.8%-0.3pp	22.1%+7.0pp	19.4%+2.3pp
EBIT	$122.1M+37.5%	$146.3M+33.9%	$117.7M+33.6%	$121.1M+122%	$88.8M+56.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Insulet.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's revenue?: Insulet (PODD) generated $2.9B in revenue over the trailing twelve months, up 31.9% year over year.
Is Insulet profitable?: Insulet reported $302.8M in net income over the trailing twelve months, a 10.4% net margin.
What are Insulet's profit margins?: Gross margin is 71.0% and operating margin is 17.5%, with a 10.4% net margin.
What is Insulet's earnings per share?: Insulet's diluted EPS over the trailing twelve months is $4.29.
Where does Insulet's income statement data come from?: Every line is extracted from Insulet's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.